USD 1.13
Price
-0.01
(-0.88%)
Day Change
|
|
---|
ZVSA, ファンダメンタルスコアはnot good (ファンダメンタル = 38) そしてテクニカルスコアは ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
Deepscope 分析 |
|
41% |
In Recommendations? | Not in any sections |
Select Rate | 0.00 From 30 days period |
Watch Rate | 0.00 From 30 days period |
Social Score | 4 |
Magic Formula Rank by ROA |
N/A
|
Magic Formula Rank by ROE |
N/A
|
Magic Formula Rank by ROIC |
N/A
|
Price | 1.13 |
PBV / Sector |
0.04 / 1.80
GREAT
|
Earning Per Share | 491.97 |
PE / Sector |
0.00 / 17.15
|
PEG or PE/Growth / Sector |
N/A / 5.47
|
Average 1M Daily Value |
8.57 M
|
Average 1W Daily Value |
0.80 M
GREAT
|
Timing Factors |
|
14% |
Financial Health |
|
41% |
ポイントになる統計 |
|
37% |
配当 |
|
4% |
登録情報 |
Analyze Date | 2024-11-23 19:34:21 |
Symbol | ZVSA |
Name | ZYVERSA THERAPEUTICS INC. |
Sector | Healthcare >> Biotechnology |
Market | NASDAQ |
Listed Shares | 2.34 M |
Par Value | N/A |
Calculated From | Quarter |
Sign | N/A |
Market Cap (M.USD) / Sector Average | 2.65 / 3,546.86 |
ニュース |
Estimation Consensus | See at WSJ.com |
Full details | See at WSJ.com |
Chart | See in Chart feature |
News | See at Yahoo Finance |